Not currently recruiting at UCSD
CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at San Diego, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- CSL Behring
- ID
- NCT04656418
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated